AUSTRALIA AND NEW ZEALAND:
Final approval hoped to be received before the end of October 2020.
Approval will be another milestone for EDE and EdenCrete and IMVHO it will be well received by investors.
US EDENCRETE® PATENT ALLOWED:
¬ US patent application no. 15/597,198 allowed - includes 24 claims directed to the production of the EdenCrete® family of products.
EDENPLAST:
¬ US Patent No. 10,472,240 issued - includes 16 claims directed to the production of the EdenPlast® family of products.
¬ A Japanese plastics company expressed an interest in testing EdenPlast® and a concentrated master batch has been prepared in Australia and sent to Japan for testing by the Japanese company.
EUROPE:
¬ Extensive trials of EdenCrete® products by a large European construction company commenced in July 2019 and were scheduled to be completed in the first half of 2020. However due to COVID 19, the trials were shut down from February 2020 until August 2020 and at the
date of this report these trials have recommenced, with finalisation anticipated before the end of CY2020.
- Forums
- ASX - By Stock
- EDE
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-2
-
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.517M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 181024981 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 7742712 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 181024981 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 7742712 | 7 |
0.003 | 41584318 | 20 |
0.004 | 12649367 | 8 |
0.005 | 360000 | 1 |
0.006 | 2831956 | 1 |
Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
Featured News
EDE (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online